Sinopharm Group Co Ltdis A Leading Chinese Pharmaceutical Company Based In Shanghaiestablished In January 2003It Operates As A Subsidiary Of China National Pharmaceutical Group Corp And Is Listed On The Stock Exchange Of Hong Kong Limitedsinopharm Is Recognized For Its Extensive Servicesincluding Distribution And Logistics For Pharmaceutical And Healthcare Productsmanufacturing Of Pharmaceuticals And Laboratory Suppliesand Retail Operations Through A Chain Of Medicine Stores In China The Company Has A Diverse Product Portfolio That Includes Various Pharmaceuticalschemical Reagentsand Laboratory Suppliesnotablysinopharm Developed The Bibp Corv Covid 19 Vaccinewhich Has Been Utilized Globallyespecially In Areas Where Mrna Vaccines Are Less Feasible Due To Storage Requirementssinopharm Serves A Wide Range Of Customersincluding Hospitalsprimary Health Service Institutionsretail Drug Storesand Government Organizationsmaking It A Significant Player In The Global Pharmaceutical Industry
